Market Overview

Morgan Stanley Reiterates Overweight, Raises PT On NanoString Technologies On Increased Visibility


In a report published Tuesday, Morgan Stanley analyst Steve Beuchaw reiterated an Overweight rating on NanoString Technologies Inc. (NASDAQ: NSTG), and raised the price target from $16.00 to $17.00.

In the report, Morgan Stanley noted, "The company's success in the biopharma space remains underappreciated, with placements at over half of mid/large pharma companies.The ~50 instruments in biopharma are driving +50% of consumables sales, implying +$250K annual consumable pull through per instrument and illustrating upside potential. The absence of further pharma collaboration revenue in '15 guidance is a driver of conservatism, worth 5% upside risk to revenues; NSTG notes ongoing interest from biopharma companies in CDx collaborations which would support sales and cash flow (note CELG cash flows $14mn in '14-'15)."

NanoString Technologies closed on Monday at $11.27.

Latest Ratings for NSTG

Oct 2018MaintainsEqual-WeightEqual-Weight
Sep 2018MaintainsOutperformOutperform
Jul 2018MaintainsEqual-WeightEqual-Weight

View More Analyst Ratings for NSTG
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Steve BeuchawAnalyst Color Price Target Analyst Ratings


Related Articles (NSTG)

View Comments and Join the Discussion!

Latest Ratings

WEEDMKM PartnersMaintains30.0
NKTRH.C. WainwrightMaintains32.0
GOODNational SecuritiesInitiates Coverage On25.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Will The Apple Watch Come Up Short? JP Morgan Responds To Rumors

Benzinga's Top Upgrades